Clinical Trials Directory

Trials / Unknown

UnknownNCT02675010

Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study

Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Multicenter Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

There are controversies about the best sites -biopsy based -tests for H pylori associated gastritis. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

Detailed description

. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia. 400 patients with dyspepsia are planned to be enrolled in this study. in addition to the routine antral biospy, corpus biospies are taken to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.

Conditions

Interventions

TypeNameDescription
OTHERENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODYENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Timeline

Start date
2014-06-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-02-05
Last updated
2016-03-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02675010. Inclusion in this directory is not an endorsement.